ARCHIVES

ACS Concludes That Laetrile Organization Is Insignificant

This article is from The Cancer Letter archive.

Vol. 17 No. 46 | November 29, 1991

Download PDF Visit The Full Archive

Related Articles

Task Force: No Routine Mammograms Until 50

November 20, 2009

NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer

August 26, 2005

Kimes: Centers Need New $$ Sources; Fox Chase, U.Pa Go Seperate Ways

October 12, 1990

Accelerated Approval Will No Longer Block Competitors, FDA Commissioner Says

June 6, 2003

In Brief: Broder Keynote Speaker At ACCC Meeting; Tefft To Head Radiation Therapy At Cleveland Clinic

February 24, 1989

NIH Offers Grant Funds for Support of Minority, Disabled Researchers

February 16, 1996